Peter LaCamera

1.4k total citations · 1 hit paper
18 papers, 955 citations indexed

About

Peter LaCamera is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Peter LaCamera has authored 18 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 2 papers in Surgery. Recurrent topics in Peter LaCamera's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Eosinophilic Disorders and Syndromes (2 papers) and Sarcoidosis and Beryllium Toxicity Research (2 papers). Peter LaCamera is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Eosinophilic Disorders and Syndromes (2 papers) and Sarcoidosis and Beryllium Toxicity Research (2 papers). Peter LaCamera collaborates with scholars based in United States, Germany and Lebanon. Peter LaCamera's co-authors include Vasiliy V. Polosukhin, Timothy S. Blackwell, Andrew M. Tager, Andrew D. Luster, Gabriele Campanella, William K. Hart, Banu A. Karimi-Shah, Jerold Chun, John Wain and Yan Xu and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Peter LaCamera

17 papers receiving 934 citations

Hit Papers

The lysophosphatidic acid receptor LPA1 links pulmonary f... 2007 2026 2013 2019 2007 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak
    2007 626 citations Andrew M. Tager, Peter LaCamera et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter LaCamera United States 7 475 407 138 117 98 18 955
Laima Tarasevičienė-Stewart United States 10 281 0.6× 494 1.2× 143 1.0× 221 1.9× 53 0.5× 14 913
Clemens L. Bockmeyer Germany 16 483 1.0× 372 0.9× 119 0.9× 158 1.4× 29 0.3× 32 1.1k
Amy Richter United States 5 476 1.0× 695 1.7× 157 1.1× 75 0.6× 43 0.4× 6 1.1k
Michael W. Stoner United States 14 314 0.7× 338 0.8× 355 2.6× 127 1.1× 36 0.4× 28 858
Henrik ten Freyhaus Germany 17 218 0.5× 383 0.9× 87 0.6× 82 0.7× 24 0.2× 45 787
C. Bruce Alexander United States 16 257 0.5× 282 0.7× 186 1.3× 119 1.0× 88 0.9× 29 1.0k
Jeffrey R. Jacobson United States 11 335 0.7× 354 0.9× 95 0.7× 172 1.5× 112 1.1× 12 961
Hiroyuki Kaneto Japan 15 589 1.2× 303 0.7× 158 1.1× 74 0.6× 48 0.5× 47 1.4k
Henry Mang United States 13 352 0.7× 154 0.4× 55 0.4× 104 0.9× 40 0.4× 22 1.1k
Rongpei Lan United States 11 441 0.9× 136 0.3× 59 0.4× 70 0.6× 41 0.4× 11 1.1k

Countries citing papers authored by Peter LaCamera

Since Specialization
Citations

This map shows the geographic impact of Peter LaCamera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter LaCamera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter LaCamera more than expected).

Fields of papers citing papers by Peter LaCamera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter LaCamera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter LaCamera. The network helps show where Peter LaCamera may publish in the future.

Co-authorship network of co-authors of Peter LaCamera

This figure shows the co-authorship network connecting the top 25 collaborators of Peter LaCamera. A scholar is included among the top collaborators of Peter LaCamera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter LaCamera. Peter LaCamera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Khoory, Joseph & Peter LaCamera. (2025). A Devastating Demise: Acute Respiratory Distress Syndrome From Rapidly-Progressive Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A5869–A5869.
2.
Astor, Todd L., Hilary J. Goldberg, Laurie D. Snyder, et al.. (2023). Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis. Therapeutic Advances in Respiratory Disease. 17. 2683745240–2683745240. 4 indexed citations
3.
Ware, Lorraine B., Nima Soleymanlou, Daniel F. McAuley, et al.. (2023). TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial. Thorax. 78(8). 816–824. 4 indexed citations
4.
Jose, Aju, et al.. (2023). Clinical Manifestations of Subjects With the Non-Specific Pulmonary Function Test Pattern. SHILAP Revista de lepidopterología. 5(3). 100253–100253. 1 indexed citations
5.
Poudel, Ayusha, et al.. (2023). Asbestos-Related Diseases and Its Impact on Health: An Updated Review Article. 12(4). 244–255. 1 indexed citations
6.
Astor, Todd L., Hilary J. Goldberg, Laurie D. Snyder, et al.. (2020). Impact of Pre-Transplant Anti-Fibrotic Therapy for IPF Upon Lung Transplant Outcomes. A2844–A2844. 2 indexed citations
7.
Alkhatib, Ala, et al.. (2020). A Predictive Model for Acute Respiratory Distress Syndrome Mortality Using Red Cell Distribution Width. Critical Care Research and Practice. 2020. 1–6. 9 indexed citations
8.
Prasse, Antje, Murali Ramaswamy, Lin Pan, et al.. (2019). A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. Pulmonary Therapy. 5(2). 151–163. 14 indexed citations
9.
Aoun, Joe, et al.. (2019). Pulmonary edema during the Boston Marathon. Respiratory Medicine Case Reports. 27. 100845–100845. 5 indexed citations
10.
Wuyts, Wim, Danielle Antin‐Ozerkis, John T. Huggins, et al.. (2019). Serious adverse events in patients with idiopathic pulmonary fibrosis in the placebo arms of 6 clinical trials. Respiratory Medicine. 150. 120–125. 4 indexed citations
11.
McCarty, Justin C., et al.. (2019). Association between dexmedetomidine use for the treatment of alcohol withdrawal syndrome and intensive care unit length of stay. Journal of Intensive Care. 7(1). 49–49. 10 indexed citations
12.
LaCamera, Peter, et al.. (2019). Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis. Chronic Respiratory Disease. 16. 404122110–404122110. 4 indexed citations
13.
Haselkorn, Tmirah, Susan L. Limb, John L. Stauffer, et al.. (2018). Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. Pulmonary Therapy. 4(1). 103–114. 3 indexed citations
14.
15.
Price, Lori Lyn, et al.. (2017). Impact of Delayed Admission to the Intensive Care Unit from the Emergency Department upon Sepsis Outcomes and Sepsis Protocol Compliance. Critical Care Research and Practice. 2017. 1–7. 23 indexed citations
16.
Tager, Andrew M., Peter LaCamera, Barry S. Shea, et al.. (2007). The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nature Medicine. 14(1). 45–54. 626 indexed citations breakdown →
17.
Tager, Andrew M., Richard L. Kradin, Peter LaCamera, et al.. (2004). Inhibition of Pulmonary Fibrosis by the Chemokine IP-10/CXCL10. American Journal of Respiratory Cell and Molecular Biology. 31(4). 395–404. 164 indexed citations
18.
Zoeller, Raphael A., et al.. (2002). Increasing plasmalogen levels protects human endothelial cells during hypoxia. American Journal of Physiology-Heart and Circulatory Physiology. 283(2). H671–H679. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laima Tarasevičienė-Stewart Breakdown of academic impact, for papers by Clemens L. Bockmeyer Breakdown of academic impact, for papers by Amy Richter Breakdown of academic impact, for papers by Michael W. Stoner Breakdown of academic impact, for papers by Henrik ten Freyhaus Breakdown of academic impact, for papers by C. Bruce Alexander Breakdown of academic impact, for papers by Jeffrey R. Jacobson Breakdown of academic impact, for papers by Hiroyuki Kaneto Breakdown of academic impact, for papers by Henry Mang Breakdown of academic impact, for papers by Rongpei Lan
Rankless by CCL
2026